Section 2 – Product/Company Update Remote Pharmacy announces continued nationwide availability of its compounded GLP-1 ...

A specialty pharmacy provides medications for complex health needs. Some specialty pharmacies or other state-licensed pharmacies may supply compounded tirzepatide.

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

NEW ORLEANS — Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight loss and improved glucose control, new data showed ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

Discover the top 25 most expensive drugs in the U.S., including the 100% increase in Ozempic and Wegovy spending, and the 373% surge in Mounjaro's popularity.

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its October 2 decision.

New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study found, and what a doctor has to say about it.

New rules may limit the supply of compounded GLP-1 weight loss drugs — less expensive copies of Ozempic, Wegovy, Mounjaro, and Zepbound — but not every product is being pulled off the shelves.

The challenged health-related claims, regarding the benefits, efficacy, and safety of Striker Pharmacy’s compounded tirzepatide medication, appeared on Striker Pharmacy’s website and Instagram ...